157 results
8-K
EX-10.12
TXMD
TherapeuticsMD Inc
18 Feb 11
Entry into a Material Definitive Agreement
12:00am
or constituent parts of such products.
1.3 Customer. The term "Customer(s)" when used herein means any purchaser of the "Products" sold by Distributor … Customer not located in the Territory that Distributor has an existing relationship with and that Distributor desires to contact regarding
8-K
TXMD
TherapeuticsMD Inc
11 Oct 11
Entry into a Material Definitive Agreement
12:00am
measurable customer benefits differentiates VitaMed from existing competitors in the market.
VitaMed was founded by Robert Finizio and Brian Bernick, M.D … . This transformation of data is what allows VitaMed to provide significant value to patients, providers and payors by focusing on the areas of customer satisfaction
8-K/A
TXMD
TherapeuticsMD Inc
22 Nov 11
Entry into a Material Definitive Agreement
12:00am
, ultimately creating improved outcomes for all. This combination of efficient distribution and technology provides measurable customer benefits … to provide significant value to patients, providers and payors by focusing on the areas of customer satisfaction and service, product strategy
10-Q
2013 Q2
TXMD
TherapeuticsMD Inc
Quarterly report
7 Aug 13
12:00am
8-K
EX-2.1
xrcmq6hw5ea
10 Mar 22
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
7:15am
8-K
EX-99.1
5x356wk88z 4ybm
20 May 22
Regulation FD Disclosure
10:30am
8-K
EX-99.1
gpy97q 31x5r
25 Jan 13
Special Note Regarding Forward-Looking Statements
12:00am